首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >A Universal Pre-Clinical Solution for the Bioanalysis of Fully Human Therapeutic Monoclonal Antibodies in Plasma
【24h】

A Universal Pre-Clinical Solution for the Bioanalysis of Fully Human Therapeutic Monoclonal Antibodies in Plasma

机译:血浆中全人治疗单克隆抗体的生物分析的通用前临床溶液

获取原文

摘要

A MSIA for universal application in the bioanalysis of fully human therapeutic mAbs for pre-clinical research is achievable. Both the raw and the deconvolved HRAM mass spectra generated clearly showed the presence of posttranslational modifications on adalimumab and SILULite from Sigma (data not shown), thus making MSIA amiable for complex in vivo biotransformation studies and Drug Antibody Ratio (DAR) determination.
机译:可实现普遍应用在临床前研究中全人治疗MAB的生物分析中的MSIA。生成的原始和解向HRAM质谱层都显示出从Sigma(未示出的数据)上对Adalimalab和硅藻土的发生发生后改变的存在,从而使MSIA在体内生物转化研究中复合物和药物抗体比(DAR)测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号